Journal News

ASBMB journals will be fully open access in 2021

ASBMB Today Staff
May 11, 2020

Earlier today, the American Society for Biochemistry and Molecular Biology announced that its three peer-reviewed journals will become, as of January, open access. You can read the announcement in full below. The society also created a page with frequently asked questions.


As elected, editorial and administrative leaders of the American Society for Biochemistry and Molecular Biology, we are pleased to announce that the society’s three highly regarded journals — Journal of Biological Chemistry, Molecular & Cellular Proteomics and Journal of Lipid Researchwill be fully open access beginning in January 2021.

The ASBMB exists to meet the needs and respond to the demands of its members, and our members, in line with the broader scientific community, have called for immediate and free public access to research published in ASBMB journals in order to reduce barriers to scientific knowledge and accelerate discoveries.

ASBMB journals have for years made accepted manuscripts immediately available for free as Papers in Press and have embargoed the final redacted versions of articles for subscribers for only a single year. In addition, authors have had the option to pay an additional fee for immediate open access of the final version of a paper or upload the accepted version for free to a public repository. As of January, the final versions of all articles will be immediately available to everyone, qualifying ASBMB journals as “gold” open access. This is important because an increasing number of funders of biomedical research are requiring its grantees to publish in only “gold” journals.

Our decision-making process was careful and consultative. During our months-long deliberations, we had to balance what is best for science and scientists with what is sustainable for a nonprofit organization. Ultimately, we determined that the ASBMB cannot achieve its goal of full open access alone, so we made the strategic decision to enter into an agreement with the commercial publisher Elsevier, which has experience transitioning subscription journals to full open access and the requisite technical expertise and infrastructure.

We want to emphasize that this agreement will not change the peer-review process at any of our journals. JBC, MCP and JLR remain committed to rigorous, fast and fair review — by active scientists.

We are happy to report, also, that the agreement will smooth the submission process for authors and reduce the cost of open-access publishing — for both members and nonmembers alike. It also will make our journals easier to read on mobile devices, discoverable on the platform ScienceDirect and, generally speaking, more nimble technologically.

Transitioning from a subscription model to an open-access model is complicated, but we know this is the right decision for the ASBMB. Throughout our deliberations, we kept focused on our goal: to make the high-quality papers we publish immediately and permanently available for everyone to read, download, copy and distribute.

We will share more information on the transition in the months to come. In the meantime, we hope that you will reach out to us if you have any questions or concerns.

Sincerely,

Gerald Hart (President, ASBMB)
Joan Conaway (Treasurer, ASBMB)
Sandra Weller (Chair, ASBMB Publications Committee)
Toni Antalis (President-elect, ASBMB)
Lila M. Gierasch (Editor-in-Chief, Journal of Biological Chemistry)
Alma Burlingame (Editor-in-Chief, Molecular & Cellular Proteomics)
Kerry-Anne Rye and Nicholas O. Davidson (Co-Editors, Journal of Lipid Research)
Barbara Gordon (Executive Director, ASBMB)
Nancy Rodnan (Senior Director, ASBMB Publications)
Steve Miller (Deputy Executive Director and Chief Financial Officer, ASBMB)

Enjoy reading ASBMB Today?

Become a member to receive the print edition monthly and the digital edition weekly.

Learn more
ASBMB Today Staff

This article was written by a member or members of the ASBMB Today staff.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Bertrand Coste and the pressure receptor
Feature

Bertrand Coste and the pressure receptor

Jan. 27, 2022

“It was almost one of those ‘I can’t believe you’re doing this’ kind of projects.” The search for a protein that senses pressure. Part of a series on the 2021 Nobel Prize in physiology or medicine.

David McKemy and the cold receptor
Feature

David McKemy and the cold receptor

Jan. 26, 2022

“This is the nature of doing bench work. We all go through those periods when stuff’s not working.” How persistence unlocked the cold-sensitive receptor TRPM8. Part of a series on the 2021 Nobel Prize in physiology or medicine.

How the Julius lab found that an ion channel senses heat
Feature

How the Julius lab found that an ion channel senses heat

Jan. 25, 2022

“Holy cow, this is why hot peppers are hot.” How researchers established that the capsaicin receptor also recognizes heat. Part of a series on the 2021 Nobel Prize in physiology or medicine.

Michael Caterina and the capsaicin receptor
Feature

Michael Caterina and the capsaicin receptor

Jan. 24, 2022

Being scooped left a postdoc with a toolkit for hunting receptors — and a daring new project. First in a series on the 2021 Nobel Prize in physiology or medicine.

Genetic analysis hints at why COVID-19 can mess with smell
News

Genetic analysis hints at why COVID-19 can mess with smell

Jan. 23, 2022

People with variants near smell-related genes may have a higher risk of losing smell or taste.

The coronavirus may cause fat cells to miscommunicate, leading to diabetes
News

The coronavirus may cause fat cells to miscommunicate, leading to diabetes

Jan. 22, 2022

COVID-19 patients with high blood sugar had low levels of a hormone made by fat.